The past, present and future of imaging in multiple sclerosis

Journal of Clinical Neuroscience

Volumn 17, Issue 4, 2010, Pages 422-427

  Ramli, N ^a   Rahmat, K ^a   Azmi, K ^a   Chong, H T ^a  

^a UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

CT scan; Imaging criteria; MRI; Multiple sclerosis

Indexed keywords

GADOLINIUM;

CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; DEMYELINATION; DIAGNOSTIC IMAGING; DIFFUSION TENSOR IMAGING; ENCEPHALOMYELITIS; HUMAN; MIDDLE CEREBELLAR PEDUNCLE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REVIEW;

BRAIN; DIAGNOSTIC IMAGING; HUMANS; MULTIPLE SCLEROSIS;

EID: 77349093490     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2009.09.014     Document Type: Review

References (52)

1. Charcot J. Histologie de la sclerose en plaques vol. 41 (1868), Gazette des Hopitaux, Paris p. 554-5
2. Schumacher G.A., Beebe G., Kebler R.F., et al. Problems of experimental trials of therapy in multiple sclerosis. Ann NY Acad Sci 122 (1965) 552-568
3. Hershey L.A., Gado M.H., and Trotter J.L. Computerized tomography in the diagnostic evaluation of multiple sclerosis. Ann Neurol 5 (1979) 32-39
4. Haughton V.M., Ho K.C., Williams A.L., et al. CT detection of demyelinated plaques in multiple sclerosis. Am J Roentgenol 132 (1979) 213-215
5. Cala L.A., Mastaglia F.L., and Black J.L. Computerized tomography of brain and optic nerve in multiple sclerosis. Observations in 100 patients, including serial studies in 16. J Neurol Sci 36 (1978) 411-426
6. Paty D.W., Oger J.J., Kastrukoff L.F., et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 38 (1988) 180-185
7. Sears E.S., McCammon A., Bigelow R., et al. Maximizing the harvest of contrast enhancing lesions in multiple sclerosis. Neurology 32 (1982) 815-820
8. Spiegel S.M., Viñuela F., Fox A.J., et al. CT of multiple sclerosis: reassessment of delayed scanning with high doses of contrast material. Am J Roentgenol 145 (1985) 497-500
9. Poser C.M. Diagnostic criteria for multiple sclerosis: an addendum. Ann Neurol 22 (1987) 773
10. McDonald W.I., Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50 (2001) 121-127
11. Barkhof F., Filippi M., Miller D.H., et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120 (1997) 2059-2069
12. Tintore M., Rovira A., Martinez M.J., et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. Am J Neuroradiol 21 (2000) 702-706
13. Polman C.H., Reingold S.C., Edan G., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald criteria". Ann Neurol 58 (2005) 840-846
14. Young I.R., Hall A.S., Pallis C.A., et al. Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet 2 (1981) 1063-1066
15. Dalton C.M., Brex P.A., Miszkiel K.A., et al. New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes. Ann Neurol 53 (2003) 673-676
16. Frohman E.M., Goodin D.S., Calabresi P.A., et al. The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 61 (2003) 602-611
17. Fazekas F., Offenbacher H., Fuchs S., et al. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology 38 (1988) 1822-1825
18. Ruddick R., and Cohen J. Multiple sclerosis or masquerade: accurate diagnosis for early treatment. AAN Direct 26 (1999) 8-12
19. Swanton J.K., Fernando K.T., Dalton C.M., et al. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry 77 (2006) 830-833
20. Miller D.H., Filippi M., Fazekas F., et al. Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis. Ann Neurol 56 (2004) 273-278
21. Herndon R.M., Coyle P.K., Murray T.J., et al. Report of the consensus panel on the new international panel guidelines for diagnosis of MS. Int J MS Care 4 (2002) 170-173
22. Rovira A., Swanton J., Tintore M., et al. A Single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. Arch Neurol 66 (2009) 587-592
23. Swanton J.K., Rovira A., Tintore M., et al. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol 6 (2007) 677-686
24. Broome D.R., Girguis M.S., Baron P.W., et al. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. Am J Roentgenol 188 (2007) 586-592
25. Penfield J.G. Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents. Pediatr Nephrol 23 (2008) 2121-2129
26. Lu C.F., Hsiao C.H., and Tjiu J.W. Nephrogenic systemic fibrosis developed after recovery from acute renal failure: gadolinium as a possible aetiological factor. J Eur Acad Dermatol Venereol 23 (2009) 339-340
27. Lucchinetti C., Bruck W., Parisi J., et al. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47 (2000) 707-717
28. Pascual A.M., Martínez-Bisbal M.C., Boscá I., et al. Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis. Neurology 69 (2007) 63-67
29. Simon J.H., Li D., Traboulsee A., et al. Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines. Am J Neuroradiol 27 (2006) 455-461
30. Charil A., Yousry T.A., Rovaris M., et al. MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation". Lancet Neurol 5 (2006) 841-852
31. Wattjes M.P., and Barkhof F. High field MRI in the diagnosis of multiple sclerosis: high field-high yield? Review. Neuroradiology 51 (2009) 279-292
32. Keiper M.D., Grossman R.I., Hirsch J.A., et al. MR identification of white matter abnormalities in multiple sclerosis: a comparison between 1.5 T and 4 T. Am J Neuroradiol 19 (1998) 1489-1493
33. Di Perri C., Dwyer M.G., Wack D.S., et al. Signal abnormalities on 1.5 and 3 Tesla brain MRI in multiple sclerosis patients and healthy controls. A morphological and spatial quantitative comparison study. Neuroimage 47 (2009) 1352-1362
34. Wattjes M.P., Lutterbey G.G., Harzheim M., et al. Higher sensitivity in the detection of inflammatory brain lesions in patients with clinically isolated syndromes suggestive of multiple sclerosis using high field MRI: an intraindividual comparison of 1.5 T with 3.0 T. Eur Radiol 16 (2006) 2067-2073
35. Wattjes M.P., Harzheim M., Kuhl C.K., et al. Does high-field MR imaging have an influence on the classification of patients with clinically isolated syndromes according to current diagnostic MR imaging criteria for multiple sclerosis?. Am J Neuroradiol 27 (2006) 1794-1798
36. Tseng GHC, Talavage TM, Hinks RS. Repeatability and variability of noise generated during MRI. In: Proceedings of the 26th annual international conference of the IEEE EMBS, vol. 2; 2004. p. 1096-99.
37. Mori S., Wakana S., Nagae-Poetscher L.M., et al. MRI atlas of human white matter (2005), Elsevier, Amsterdam
38. Cader S., Johansen-Berg H., Wylezinska M., et al. Discordant white matter N-acetylasparate and diffusion MRI measures suggest that chronic metabolic dysfunction contributes to axonal pathology in multiple sclerosis. Neuroimage 36 (2007) 19-27
39. Beaulieu C., and Allen P.S. Determinants of anisotropic water diffusion in nerves. Magn Reson Med 31 (1994) 394-400
40. Werring D.J., Clark C.A., Barker G.J., et al. Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology 52 (1999) 1626-1632
41. Tievsky A.L., Ptak T., and Farkas J. Investigation of apparent diffusion coefficient and diffusion tensor anisotropy in acute and chronic multiple sclerosis lesions. Am J Neuroradiol 20 (1999) 1491-1499
42. Hajnal J.V., Doran M., Hall A.S., et al. MR imaging of anisotropically restricted diffusion of water in the central nervous system: technical, anatomic, and pathologic considerations. J Comput Assist Tomogr 15 (1991) 1-18
43. Ulug A.M., Moore D.F., Bojko A.S., et al. Clinical use of diffusion-tensor imaging for diseases causing neuronal and axonal damage. Am J Neuroradiol 20 (1999) 1044-1048
44. Sorensen A.G., Wu O., Copen W.A., et al. Human acute cerebral ischemia: detection of changes in water diffusion anisotropy by using MR imaging. Radiology 212 (1999) 785-792
45. McGowan J.C., Filippi M., Campi A., et al. Magnetisation transfer imaging: theory and application to multiple sclerosis. J Neurol Neurosurg Psychiatry 64 Suppl. 1 (1998) S66-S69
46. Brochet B., and Dousset V. Pathological correlates of magnetization transfer imaging abnormalities in animal models and humans with multiple sclerosis. Neurology 53 (1999) S12-S17
47. Gonsette R.E. Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity. J Neurol Sci 274 (2008) 48-53
48. Mader I., Roser W., Kappos L., et al. Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques: absolute metabolic values over 2 years during a clinical pharmacological study. Am J Neuroradiol 21 (2000) 1220-1227
49. Anderson S.A., Shukaliak-Quandt J., Jordan E.K., et al. Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Ann Neurol 55 (2004) 654-659
50. Bendszus M., Ladewig G., Jestaedt L., et al. Gadofluorine M enhancement allows more sensitive detection of inflammatory CNS lesions than T2-w imaging: a quantitative MRI study. Brain 131 (2008) 2341-2352
51. Miller D.H., Thompson A.J., and Filippi M. Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis. J Neurol 250 (2003) 1407-1419
52. Bakshi R., Thompson A.J., Rocca M.A., et al. MRI in multiple sclerosis: current status and future prospects. Lancet Neurol 7 (2008) 615-625